Adverse reactions were reported in 202 of 3,196 patients (6.3%) in post marketing observational study in Japan. The major adverse reactions were eye irritation in 30 patients (0.9%), eye discharge in 30 patients (0.9%), eye pain in 22 patients (0.7%), lacrimation increased in 20 patients (0.6%) and blepharitis in 19 patients (0.6%), etc.
If an adverse drug reaction is observed, appropriate measures including discontinuing administration should be taken. (See Table 5.)
Click on icon to see table/diagram/image
Incidence was calculated based on the clinical study results up to approval.
Immune system disorders: Frequency not known: Hypersensitivity including anaphylactic shock.
View ADR Monitoring Form